SI2226381T1 - Postopek za gojenje celic za proizvodnjo snovi - Google Patents

Postopek za gojenje celic za proizvodnjo snovi

Info

Publication number
SI2226381T1
SI2226381T1 SI200332473A SI200332473A SI2226381T1 SI 2226381 T1 SI2226381 T1 SI 2226381T1 SI 200332473 A SI200332473 A SI 200332473A SI 200332473 A SI200332473 A SI 200332473A SI 2226381 T1 SI2226381 T1 SI 2226381T1
Authority
SI
Slovenia
Prior art keywords
glucose
limitation
dgl
qglc
cells
Prior art date
Application number
SI200332473A
Other languages
English (en)
Slovenian (sl)
Inventor
Ruth Essers
Jochen Gaetgens
Thomas Link
Thomas Noll
Kerstin Skopnik
Christian Wandrey
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of SI2226381T1 publication Critical patent/SI2226381T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200332473A 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi SI2226381T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255508A DE10255508A1 (de) 2002-11-27 2002-11-27 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
EP10152393.4A EP2226381B1 (de) 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen

Publications (1)

Publication Number Publication Date
SI2226381T1 true SI2226381T1 (sl) 2016-05-31

Family

ID=32318751

Family Applications (3)

Application Number Title Priority Date Filing Date
SI200332473A SI2226381T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi
SI200332602T SI2275530T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi
SI200331791T SI1585810T1 (sl) 2002-11-27 2003-11-07 Postopek gojenja celic za proizvodnjo substanc

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI200332602T SI2275530T1 (sl) 2002-11-27 2003-11-07 Postopek za gojenje celic za proizvodnjo snovi
SI200331791T SI1585810T1 (sl) 2002-11-27 2003-11-07 Postopek gojenja celic za proizvodnjo substanc

Country Status (12)

Country Link
US (2) US20060127975A1 (enExample)
EP (3) EP1585810B1 (enExample)
JP (2) JP4469283B2 (enExample)
AT (1) ATE462013T1 (enExample)
CY (2) CY1110267T1 (enExample)
DE (2) DE10255508A1 (enExample)
DK (2) DK1585810T3 (enExample)
ES (3) ES2749217T3 (enExample)
HU (1) HUE028862T2 (enExample)
PT (1) PT1585810E (enExample)
SI (3) SI2226381T1 (enExample)
WO (1) WO2004048556A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312184T3 (es) 1997-03-21 2009-02-16 Chugai Seiyaku Kabushiki Kaisha Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas.
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
EP1623019B2 (en) 2003-05-15 2017-01-25 Wyeth LLC Restricted glucose feed for animal cell culture
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
AU2015203309B2 (en) * 2009-10-26 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
AU2016210748B2 (en) * 2009-10-26 2018-03-01 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
KR102071834B1 (ko) * 2009-10-26 2020-01-30 에프. 호프만-라 로슈 아게 글리코실화된 면역글로불린의 제조 방법
TWI563090B (en) * 2009-12-22 2016-12-21 Dsm Ip Assets Bv The preparation of caprolactam from 6-amino caproic acid obtained in a fermentation process
EP2638067A2 (en) 2010-11-08 2013-09-18 Genentech, Inc. Subcutaneously administered anti-il-6 receptor antibody
RU2674996C2 (ru) 2013-07-04 2018-12-14 Ф. Хоффманн-Ля Рош Аг Иммуноферментный анализ с подавлением интерференции для определения антител к лекарствам в образцах сыворотки
ES3005909T3 (en) 2014-03-19 2025-03-17 Pfizer Method of cell culture
WO2017051347A2 (en) 2015-09-23 2017-03-30 Pfizer Inc. Cells and method of cell culture
EP3891292A1 (en) 2018-12-06 2021-10-13 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657863A (en) * 1982-07-02 1987-04-14 Celanese Corporation Stabilization of a mutant microorganism population
JPH066054B2 (ja) * 1987-10-15 1994-01-26 帝人株式会社 動物細胞の培養方法
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
US5443968A (en) 1992-05-01 1995-08-22 Teijin Limited Fed batch culture method for protein secreting cells
GB9506249D0 (en) * 1995-03-27 1995-05-17 Karobio Ab Media for insect cell cultures
US6156570A (en) * 1997-03-20 2000-12-05 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6338964B1 (en) * 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration

Also Published As

Publication number Publication date
PT1585810E (pt) 2010-05-05
JP4469283B2 (ja) 2010-05-26
DK2226381T3 (en) 2016-04-11
EP2275530A3 (de) 2012-05-23
CY1117558T1 (el) 2017-04-26
SI2275530T1 (sl) 2019-11-29
WO2004048556A1 (de) 2004-06-10
ES2340377T3 (es) 2010-06-02
EP2275530B1 (de) 2019-08-07
US20140329277A1 (en) 2014-11-06
EP2226381B1 (de) 2016-03-09
EP2226381A1 (de) 2010-09-08
DE50312554D1 (de) 2010-05-06
HUE028862T2 (en) 2017-01-30
EP1585810B1 (de) 2010-03-24
SI1585810T1 (sl) 2010-06-30
ES2567161T3 (es) 2016-04-20
ES2749217T3 (es) 2020-03-19
US20060127975A1 (en) 2006-06-15
DK1585810T3 (da) 2010-06-07
JP2006507821A (ja) 2006-03-09
JP2010110331A (ja) 2010-05-20
ATE462013T1 (de) 2010-04-15
CY1110267T1 (el) 2015-01-14
JP5221573B2 (ja) 2013-06-26
EP2275530A2 (de) 2011-01-19
DE10255508A1 (de) 2004-06-17
EP1585810A1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
NZ596420A (en) Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
EP1513940A4 (en) METHOD AND MATERIALS FOR THE PRODUCTION OF MILKY ACID IN YEAST
DK1623019T3 (da) Begrænset glucosetilførsel til dyrecellekultur
YU55100A (sh) Postupak za fermentacionu proizvodnju d-pantotenske kiseline upotrebom bakterija korinskog oblika
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
BRPI0516261A (pt) método para produzir uma substãncia básica por fermentação, e, caldo de fermentação ou produto de fermentação contendo uma substáncia básica
BR0200285A (pt) Bactéria corineforme, e método para a produção de l-cisteìna
TR200401091T4 (tr) Gelişim faktörleri ve L-glutamin içeren hücre kültürü besiyeri
EP1571223A3 (en) L-cysteine-producing microorganism and a method for producing L-cysteine
IL160445A0 (en) A unit and a process for carrying out high cell density fermentation
EP4406615A3 (en) Method for the production of a glycosylated immunoglobulin
UA92157C2 (ru) Способ продуцирования гормона роста
EP1687413B8 (en) Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
WO2004029260A3 (en) Astaxanthin production using fed-batch fermentation process by phaffia rhodozyma
ATE386134T1 (de) Verfahren zur herstellung von glutathion
FR2798141B1 (fr) Procede de production d'exopolysaccharides
AU2001243667A1 (en) Method of aerating yeast prior to pitching
AU2003273521A1 (en) Production method of iturin a and its homologues
WO2001020016A3 (de) Verfahren zur steigerung der ausbeute von rekombinanten proteinen in mikrobiellen fermentationsprozessen
AU2002214085A1 (en) Method for producing proteins by electroporation
DE50013563D1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
AU2003242533A1 (en) Glutamine-free medium
DE59911877D1 (de) Verfahren zur verbesserung des gentransfers von genetischem material in säugerzellen durch die verwendung von p21 (waf-1)
WO2004087860A3 (en) Materials and methods for regulating process formation in cell culture